Benjamin Rengstl

An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors

Katharina Reinhard, Benjamin Rengstl, Petra Oehm et al. · Science · 2020 · 507 citations

Medicine, Immunology, Oncology +17

CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial

Andréas Mackensen, John B.A.G. Haanen, Christian Koenecke et al. · Nature Medicine · 2023 · 261 citations · Full text

Medicine, Immunology, Oncology +17

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?

Sylvia Hartmann, Claudia Döring, Christina Jakobus et al. · PLoS ONE · 2013 · 115 citations · Full text

Medicine, Hematology, Pathology +16

Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma

Sylvia Hartmann, Bianca Schuhmacher, Tobias Rausch et al. · Leukemia · 2015 · 100 citations

Medicine, Oncology, Pathology +10

Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed–Sternberg cells

Benjamin Rengstl, Sebastian Newrzela, Tim Heinrich et al. · Proceedings of the National Academy of Sciences · 2013 · 86 citations · Full text

Veterinary Medicine, Cell Biology, Oncology +12